Bristol Myers Squibb pays Atrium Therapeutics $15M milestone
Atrium Therapeutics earns a $15 million milestone payment from Bristol Myers Squibb under a global cardiovascular collaboration, per Newsdesk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.